GF Fund Management’s iTeos Therapeutics ITOS Stock Holding History

GF Fund Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-935	Closed	-$9.32K	–	658
2025 Q2	$9.32K	Hold	935	–	–	﹤0.01%	577
2025 Q1	$5.58K	Buy	935 +168	+22%	+$1.23K	﹤0.01%	618
2024 Q4	$5.89K	Buy	+767	New	+$6.59K	﹤0.01%	602

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

GF Fund Management's ITOS Position: Q3 2025 in Review

GF Fund Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 935 shares — an estimated $9.32K sold.

GF Fund Management first reported a position in ITOS in Q4 2024 and held it in 3 quarters. The position peaked at $9.32K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

GF Fund Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
GF Fund Management sold 935 iTeos Therapeutics shares in Q3 2025, an estimated $9.32K.
GF Fund Management first reported a position in iTeos Therapeutics in Q4 2024 and held it in 3 quarters.
GF Fund Management's iTeos Therapeutics position peaked at $9.32K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on GF Fund Management's 13F filing for Q3 2025, filed 7 Nov 2025.